November 5, 2015 · STOCK Act disclosure
Representative John K. Delaney (Democrat-MD) bought Alnylam Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on November 5, 2015 and was disclosed on December 1, 2015 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.